Bexarotene Gel: A Food and Drug Administration–Approved Skin-Directed Therapy for Early-Stage Cutaneous T-Cell Lymphoma.
Autor: | Liu, Howard L., Kim, Youn H. |
---|---|
Předmět: | |
Zdroj: | Archives of Dermatology; Mar2002, Vol. 138 Issue 3, p398, 2p |
Abstrakt: | Demonstrates that bexarotene gel, a retinoid X receptor-selective retinoid, is well tolerated as a topical therapy for cutaneous T-cell lymphoma (CTCL); Response rate of patients with early CTCL. |
Databáze: | Complementary Index |
Externí odkaz: |
načítá se...